UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

Neurology, 2006-04, Vol.66 (7), p.996-1002

2006

Volltextzugriff (PDF)

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2008-05, Vol.70 (19), p.1699-1706

2008

Volltextzugriff (PDF)

Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD

Neurology, 2010-11, Vol.75 (19), p.1711-1716

2010

Volltextzugriff (PDF)

Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2008-05, Vol.70 (19), p.1691-1698

2008

Volltextzugriff (PDF)

Prospective prevalence of pathologic gambling and medication association in Parkinson disease

Neurology, 2006-06, Vol.66 (11), p.1750-1752

2006

Volltextzugriff (PDF)

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study

Brain (London, England : 1878), 2009-05, Vol.132 (5), p.1376-1385

2009

Volltextzugriff (PDF)

Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia

Neurology, 2007-02, Vol.68 (6), p.457-459

2007

Volltextzugriff (PDF)

Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology

Neurology, 2010-03, Vol.74 (11), p.924-931

2010

Volltextzugriff (PDF)

Prevalence of repetitive and reward-seeking behaviors in Parkinson disease

Neurology, 2006-10, Vol.67 (7), p.1254-1257

2006

Volltextzugriff (PDF)

Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology

Neurology, 2002-01, Vol.58 (1), p.11-17

2002

Volltextzugriff (PDF)

Palliative stage Parkinson’s disease: patient and family experiences of health-care services

Palliative medicine, 2009-03, Vol.23 (2), p.120-125

2009

Volltextzugriff (PDF)

Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

Neurology, 2006-04, Vol.66 (7), p.983-995

2006

Volltextzugriff (PDF)

Palliative care and movement disorders

Journal of the neurological sciences, 2019-10, Vol.405, p.64-64

Miyasaki, J.

2019

Volltextzugriff (PDF)

Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines

Neurology, 2008-07, Vol.71 (1), p.57-63

2008

Volltextzugriff (PDF)

Effect of GPi pallidotomy on motor function in Parkinson's disease

The Lancet (British edition), 1995-11, Vol.346 (8987), p.1383-1387

1995

Volltextzugriff (PDF)

Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology

Neurology, 2012-08, Vol.79 (6), p.597-603

2012

Volltextzugriff (PDF)

Mobility, mood and site of care impact health related quality of life in Parkinson's disease

Parkinsonism & related disorders, 2014-03, Vol.20 (3), p.274-279

2014

Volltextzugriff (PDF)

AAN guidelines: a benefit to the neurologist

Neurology, 2010-09, Vol.75 (13), p.1126-1127

2010

Volltextzugriff (PDF)

Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2010-05, Vol.74 (18), p.1463-1470

2010

Volltextzugriff (PDF)

Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review)

Neurology, 2009-09, Vol.73 (9), p.736; author reply 737-738

2009

Volltextzugriff (PDF)

Assessment: efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2010-01, Vol.74 (2), p.173-176

2010

Volltextzugriff (PDF)

Invited article: Neurology and quality improvement: an introduction

Neurology, 2008-04, Vol.70 (18), p.1636-1640

2008

Volltextzugriff (PDF)

Psychogenic movement disorders

Canadian journal of neurological sciences, 2003-02, Vol.30 Suppl 1 (S1), p.S94-S100

2003

Volltextzugriff (PDF)

Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice

Nature genetics, 2013-09, Vol.45 (9), p.1077-1082

2013

Volltextzugriff (PDF)

Levodopa and the Progression of Parkinson's Disease

The New England journal of medicine, 2004-12, Vol.351 (24), p.2498-2508

2004

Volltextzugriff (PDF)

1 – 25 von 157

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(137)
Mit Volltextzugriff
(89)

Publikationsform

Artikel
(156)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(107)
Life Sciences & Biomedicine
(104)
Humans
(101)
Neurosciences & Neurology
(59)
Biological And Medical Sciences
(55)
Clinical Neurology
(52)
Male
(49)
Medical Sciences
(47)
Female
(45)
Middle Aged
(39)
Neurology
(37)
Aged
(29)
Parkinson's Disease
(26)
Adult
(21)
Parkinson Disease - Drug Therapy
(18)
Nervous System
(11)
Parkinson Disease - Physiopathology
(11)
Treatment Outcome
(11)
United States
(11)
Animals
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD

Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Prospective prevalence of pathologic gambling and medication association in Parkinson disease

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study

Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia

Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology

Prevalence of repetitive and reward-seeking behaviors in Parkinson disease

Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology

Palliative stage Parkinson’s disease: patient and family experiences of health-care services

Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

Palliative care and movement disorders

Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines

Effect of GPi pallidotomy on motor function in Parkinson's disease

Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology

Mobility, mood and site of care impact health related quality of life in Parkinson's disease

AAN guidelines: a benefit to the neurologist

Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review)

Assessment: efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Invited article: Neurology and quality improvement: an introduction

Psychogenic movement disorders

Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice

Levodopa and the Progression of Parkinson's Disease

Suchergebnisse filtern